Company
United StatesGranules Pharmaceuticals Inc., Chantilly, VA – FDA Inspections
Inspection records and compliance data for Granules Pharmaceuticals Inc. in Chantilly, Virginia. 8 FDA inspections on record, 6 Form 483s, last inspected April 03, 2026.
Company Profile
This profile covers Granules Pharmaceuticals Inc. based in Chantilly, Virginia, United States.
FDA Inspection History
- FDA inspections
- 8
- OAI
- 0
- VAI
- 6
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 6
- Warning letters
- 0
First inspected December 8, 2017. Last inspected April 3, 2026.
Most cited issue areas
- Buildings not maintained in good state of repair2 inspections
- Equipment Design, Size and Location2 inspections
- Procedures not in writing, fully followed2 inspections
FDA inspections (8)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 3, 2026 | VAI | Human Drugs · Drug Quality Assurance | 1311002 |
| June 27, 2025 | VAI | Human Drugs · Generic Drug Evaluation | 1274604 |
| December 15, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1225087 |
| August 3, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1215034 |
| July 22, 2022 | VAI | Human Drugs · Drug Quality Assurance | 1175097 |
| August 21, 2019 | Not classified | Human Drugs | 1107374 |
| October 26, 2018 | VAI | Human Drugs · Generic Drug Evaluation | 1069969 |
| December 8, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1035023 |
FDA documents
Form 483s (10)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Granules Pharmaceuticals Inc.
FEI Number
3011585184
Address
3701 Concorde Pkwy, Chantilly, Virginia 20151, United States
Country
United States
ID: fa93bf3f-822e-47be-9e47-59b1c5446629